RCL
62
-3
SCHW
58
2
WU
44
-2
HST
39
-5
AIV
62
-2
FOX
50
2
HES
68
2
K
42
-3
XEL
60
-2
ILMN
23
-5
IP
62
-2
KHC
29
-2
DRI
63
3
KIM
51
4
CL
61
-5
NWL
35
-4
MU
56
-3
RSG
67
2
HUM
43
-4
ZION
55
2
RCL
62
-3
SCHW
58
2
WU
44
-2
HST
39
-5
AIV
62
-2
FOX
50
2
HES
68
2
K
42
-3
XEL
60
-2
ILMN
23
-5
IP
62
-2
KHC
29
-2
DRI
63
3
KIM
51
4
CL
61
-5
NWL
35
-4
MU
56
-3
RSG
67
2
HUM
43
-4
ZION
55
2
Financhill
Back

XWELL Vs. OncoCyte Industry Stock Comparison

Buy
53

XWEL
XWELL

Last Price:
1.80
Seasonality Move:
7.78%
Sell
39

OCX
OncoCyte

Last Price:
2.99
Seasonality Move:
-15.4%
Buy
53
XWELL (XWEL) is a Buy

Is XWELL a Buy, Sell or Hold?

  • The current XWELL [XWEL] share price is $1.74. The Score for XWEL is 53, which is 6% above its historic median score of 50, and infers lower risk than normal.
  • XWEL is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
39
OncoCyte (OCX) is a Sell

Is OncoCyte a Buy, Sell or Hold?

  • The current OncoCyte [OCX] share price is $2.93. The Score for OCX is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
  • OCX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

XWEL Stock Price Chart

What is XWELL's stock price today?

  • The XWELL share price today is $1.74
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and XWEL is experiencing selling pressure, which indicates risk of future bearish movement.

OCX Stock Price Chart

What is OncoCyte's stock price today?

  • The OncoCyte share price today is $2.93
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and OCX is experiencing selling pressure, which indicates risk of future bearish movement.

XWEL Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.05 Buy
Relative Strength Index (14 RSI): 49.92 Sell
Chaikin Money Flow: -5568 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (1.49 - 1.89) Buy
Bollinger Bands (100): (1.49 - 1.93) Buy

OCX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.06 Buy
Relative Strength Index (14 RSI): 57.62 Buy
Chaikin Money Flow: -24100 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (2.5 - 2.88) Buy
Bollinger Bands (100): (2.7 - 3.2) Sell

XWEL Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 1.83 Sell
20-day SMA: 1.77 Sell
50-day SMA: 1.72 Buy
200-day SMA: 2.22 Sell
8-day EMA: 1.8 Sell
20-day EMA: 1.76 Sell
50-day EMA: 1.74 Buy
200-day EMA: 2.8 Sell

OCX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 2.91 Buy
20-day SMA: 2.71 Buy
50-day SMA: 2.83 Buy
200-day SMA: 3.09 Sell
8-day EMA: 2.91 Buy
20-day EMA: 2.81 Buy
50-day EMA: 2.83 Buy
200-day EMA: 3.77 Sell

XWELL Earnings Growth & XWEL Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $3.26 per share, and a decrease next year of $0.00 per share.

OncoCyte Earnings Growth & OCX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.43 per share, an increase next quarter of $0.14 per share, a decrease this year of $0.17 per share, and an increase next year of $0.68 per share.

XWELL Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

OncoCyte Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):